chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 2/12/21,"almost two weeks after the vaccine was received, I started having sever muscle spasms. They were shooting through the right side of my neck and shoulder. Any sudden movement or wrong movement triggered the spasms.  Even taking too deep of a breath triggered the spasms.  Using my left arm to lift something triggered the spasms. My pain level that day was at a 10+. On Saturday the spasms had subsided, but I  still had very limited ROM in my neck. It felt like my neck muscles had been over worked and my neck felt weak. Pain continued and I went my doctor on Monday 2/15/21. After me explaining to him the course of events and letting him know I did not do anything at all that could have caused an injury,  he felt this was a reaction to the Covid vaccine I had gotten on 2/1/21. He advised me to take my muscle relaxer that he had already prescribed to me and to use a heating pad.  He gave me some exercises to do with my neck and prescribed me Hydrocodone 5-325 mg to take as needed every 8 hours for pain. He told me if it got worse or did not get better to follow-up with him.
red bruise like spots on the legs appeared; tiredness; feeling lethargic; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Batch/Lot Number, and Expiration Date not reported) via an unspecified route of administration on 22Feb2021 (at the age of 63-years-old), as dose 1, single for COVID-19 immunisation. Patient has no relevant medical history. There were no concomitant medications. Patient has no allergies to medications, food, or other products. Prior to vaccination, it was unknown if the patient was diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced red bruise like spots on the legs appeared, tiredness, and feeling lethargic on 28Feb2021. An appointment was made with patient's dermatologist and patient expressed a lot of anxiety about receiving the second dose. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Difficulty swallowing; Could not breath; threw up a little in her mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Difficulty swallowing), DYSPNOEA (Could not breath) and VOMITING (threw up a little in her mouth) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Food allergy (unspecified). Concomitant products included VITAMINS NOS, GLATIRAMER ACETATE (COPAXONE), MECLIZINE HCL and OMEPRAZOLE for an unknown indication.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced DYSPHAGIA (Difficulty swallowing), DYSPNOEA (Could not breath) and VOMITING (threw up a little in her mouth). At the time of the report, DYSPHAGIA (Difficulty swallowing), DYSPNOEA (Could not breath) and VOMITING (threw up a little in her mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Developed sore throat and hives one week after vaccine. Antibiotics helped sore throat, but hives persisted for two more weeks.
On 08/29/2001, This patient came to FIU complaining of fine rash all over her body. Nodes in back, neck, sore throat, rash began 08/28/01. Sore throat began 08/26/01.
Red spots on forearm on the arm I received the shot on. I noticed it 2 hours after the shot.
10 hours after the vaccine I had a fever of 105.1ºF. Every single joint in my entire body hurt worse than when I had COVID-19 December 2020. Since then (over the past year), my health has continued to decline with many new health conditions, as well as, completely unresolved COVID-19 symptoms. My long COVID-19 symptoms started resolving prior to getting the vaccine, then they came back with a full vengeance and more ever since.
Dizziness, Headache, Myalgia, Fever,  fatigue Narrative: Woke up the day after the vaccine with a headache, dizziness, slight body aches, and an elevated temperature of 99.1F. Took ibuprofen throughout the day. Symptoms resolved by the next day.
Has chicken pox - 20 or more. Contracted chicken pox from the varicella vaccine
Adverse event: Vaccine administered 16 days after beyond use date and less effective. Treatment: Pt is receiving another dose in office as recommended by Pfizer and the state they live in.
Lethargic after 1st dose; Never followed up to get 2nd dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of lethargy in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.  Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.  On an unknown date, the patient received the 1st dose of Shingrix and the did not receive 2nd dose of Shingrix. On an unknown date, 2 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced lethargy (Verbatim: Lethargic after 1st dose) and incomplete course of vaccination (Verbatim: Never followed up to get 2nd dose). The outcome of the lethargy was resolved and the outcome of the incomplete course of vaccination was unknown.  It was unknown if the reporter considered the lethargy to be related to Shingrix.  It was unknown if the company considered the lethargy to be related to Shingrix.  Additional Information: GSK Receipt Date: 24-APR-2023 The patient had called at the time of reporting (today) and stated that, about 3.5 years ago she received the first dose of Shingrix on a Friday evening. The patient stated that, she never followed up to get her second dose. The patient stated that, she planned to get the second dose on 29 April 2023. The patient stated that the following Sunday after she received her first dose she felt lethargic. The reporter had denied consent to follow-up. Until the time of reporting, the patient did not receive the second dose of vaccine, which had led to incomplete course of vaccination.
1st vaccination date: 04/10/2021 2 Kidney stone 6 days after  vaccination. Both stones passed with severe pain within 12 hour of each other.  2nd vaccination date: 05/01/2021  at 9:30 AM 2 kidney stones on 4 days after shot. first with mild pain. 2nd with severe pain and bloody urine. 1 kidney stone passed 6 days after shot with mild pain. No stones required hospitalization and passed at home. No further pain at this time - will continue to monitor. Only 2 prior events of kidney stones in 2017. NO other kideny stone events during lifetime.
I have been advising my doctor since May that my fevers and muscle pains related to an unknown disease have seemingly come back, but they were not the same as before. I spent months before this second shot working out, losing weight, correcting so many medical issues. My heart rate was one thing I paid special attention to because I was trying to make it better. I was riding miles on my bike. I was walking almost every day. My cholesterol numbers were improving. My weight was dropping. I was still working at it until July when it almost wasn't possible anymore. I suspected it was just my condition again, but it was different. It wasn't quite as bad. The fevers weren't always as high, but I still had some very high fevers. My muscle pain was different, and now it's only in a couple of spots consistently (my left side of my chest and both of my deltoids hurt consistently). I do have other pains that pop up, but that's expected.   I was starting a new job at the end of July, although I didn't know when I was going to be starting in April at the time of my shot. I took a physical (4/16/21) at my new employer the Friday following my shot (4/13/21). They actually emailed me that my start date would be delayed.   I had concerns in early May that things were returning and I suspected my condition over the vaccine at the time. It continued to get worse.   I am now taking (October 2021) 1-2 steroids (prednisone 10 mg) a day to even feel slightly normal. I have been taking steroids regularly since May or early June. Before then I took maybe 4 or 5 in a year. They helped to break my fevers.
My 2nd vaccine injection was in April 26. The next day the lymph node at my collar bone was very swollen and tender. This continued for several days until May 4th when the lymph node was no longer visibly swollen or tender to touch; however, muscle soreness in my shoulders and neck, as well as a right sided headache, has unexpectedly set in.
This spontaneous report as received from a female nurse of unknown age via a field representative refers to herself. The patient's medical history and concurrent conditions were not reported. On 14-FEB-2014 the patient was vaccinated with ZOSTAVAX (lot # not provided) 1 injection, subcutaneous. On 14-FEB-2014 the patient experienced zoster type rash at the injection site after being administered with the ZOSTAVAX, and she did not "feel well" for several days after receiving the vaccine. The patient sought unspecified medical attentions. No treatment was given for the events. After a few weeks, the patient began feeling "normal" again. The outcome of the events was reported as recovered. The relationship between ZOSTAVAX and events was not reported. Additional information has been requested.
Severe fever; Body aches; Shivering; Pain in joints; This case was reported by a consumer and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced fever, general body pain, shivering and joint pain. On an unknown date, the outcome of the fever, general body pain, shivering and joint pain were recovered/resolved.   It was unknown if the reporter considered the fever, general body pain, shivering and joint pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient's husband. The age at vaccination was not reported. The patient experienced severe fever, body aches ,shivering ,pain in joints. For tolerance to next dose of Shingrix, refer case US2019AMR195110.
sore throat, fever, headache, body aches, cough, chills, nausea, abdominal cramping, nasal congestion, rhinorrhea starting on 9/20/21
After administering the shot, the patient closed his eyes and went into symptoms what seem to be seizure for about 10-15 seconds.  The pt slide on to the floor and then open up his eyes and said "I had a dream". Seem as his heart rate was high, the ambulance was immediately called.  They came over in about 10 minutes and the pt seem fine.
Loss of peripheral vision and tunnel vision with halo; Miller Fischer variant of Guillain-Barre. The medical record received on 12/10/03 state pharyngitis, dizzy and ataxia.
Pain at injection site which turned into my arm being covered in large red hot painful welts. They don't itch, but feel bruised. I am also now nauseous and have a bad headache. Waiting to see my doctor on Monday.
Swelling in the lower right arm pit, sore and tender to the touch, accompanied by runny nose and some drainage in the ear for 1 day. Arm pit was swollen for 3 days after which the swelling went down but site was still tender to the touch for 2 weeks. Right arm pit feels a little different than left based on self examination.
Flu shot administered by wellness nurse. The patient reported to her school nurse on 9/22/2014 that her left arm had been hurting since her injection and that it was not better. Followed up by phone with the patient on 9/23/2014 and she stated that her left arm still hurt and had not improved. Stated the arm bothered her worse at night when she turned on her left side in her sleep. Advised the patient to see her personal physician if symptoms did not improve.
3x3 cm swollen red, hard lump with rash. Arm swollen from shoulder to elbow.
Past 36 days for second dose; tested positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for Covid-19) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Past 36 days for second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient received Moderna COVID vaccine by different vendor on 4/15/2021 AND 5/13/2021.  Patient then received Pfizer dose listed here on 7/31/2021 by us at.
Patient received Moderna vaccine for Prime dose on 2/23/2021. Received Pfizer as a booster dose on 3/11/2021
Fever; Strong headache; Pain in the arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEADACHE (Strong headache) and VACCINATION SITE PAIN (Pain in the arm of injection) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEADACHE (Strong headache) and VACCINATION SITE PAIN (Pain in the arm of injection). At the time of the report, PYREXIA (Fever), HEADACHE (Strong headache) and VACCINATION SITE PAIN (Pain in the arm of injection) had resolved.            No concomitant medications reported. No treatment information was provided.   Reporter did not allow further contact
25jul90 pt vax 3rd hepta B. pt ex pain on touch & w/ motion at inject site. tx w/ asa and local cold and warm compress.
Heart palpitations; difficulty taking a deep breath; hyperawareness of heartbeat, strong heart beat; This is a spontaneous report from a contactable consumer or other non hcp (Patient, self-reporting). A 38-years-old (non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EM9810 and expiration dates were not reported), via an unspecified route of administration in right arm on 18Feb2021 at 13:30 (Age at time of vaccination 38-years-old) as second dose, single for COVID-19 immunization. Medical history included autoimmune thyroiditis, mitral valve prolapse from an unknown date and unknown if ongoing. The concomitant medication included levothyroxine sodium (SYNTHROID), fish oil (OMEGA 3 COMPLETE), colecalciferol (VITAMIN D), probiotics (PROBIOTICS), liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EL9264 and expiration dates were not reported), via an unspecified route of administration in right arm on 28Jan2021 at 02:00 PM as first dose, single for COVID-19 immunization. On 18Feb2021 21:00 The patient experienced heart palpitations, difficulty taking a deep breath, hyperawareness of heartbeat, strong heart beat. The patient not experienced vaccine in four week. The patient has not covid test prior and post vaccination. The treatment was no for AE. Facility type vaccine: Hospital. The outcome of event was not recovered.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
After Fluzone 0.5 IM 10/5/09 parents note increased anxiety, increased insomnia. Now 4 wks later slowly improving.
pt recvd vax; exp sz w/in a day after vax; to er where an urticarial rash was noted on chest; admitted for observation & discharged 48 hrs later; neurological status appeared to be nl; no meds; events resolved;
This spontaneous report as received from a medical assistant refers to a 6 month old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 23-OCT-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # R007988, expiry date: 16-OCT-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source.; Sender's Comments: US-009507513-1809USA002868: Original Case : 1809USA002868 US-009507513-1902USA009324: Original Case : 1902USA009323 US-009507513-1902USA009325: Original Case : 1902USA009323 US-009507513-1902USA009323: Original Case : 1902USA009323.
Menveo vaccine given instead of Prevnar (which was due) The vaccine coordinator (which is I) noticed this mistake while entering vaccines into system, taking them out of inventory. Our clinic has a interface from our EMR  to system that automatically sends the vaccines when they are entered into our EMR system.  The vaccine coordinator brought this to nurses attention, then discussed with provider, clinic manager, notified vaccine rep., contacted communicable disease who verified child would be ok. Nurse contacted mother. Mother reports no signs, symptoms of reaction due to injection. She will continue to monitor patient and will report any change. Advised mother to bring child in for Prevnar immunization in 2-4 weeks.
Patient's Right arm is warm to touch and swollen.  It's very painful for the first 3-5 days.  Patient also experiences some small red dots for the first 3 days but it went away after 1 week.  Advise patient to take some Ibuprofen to help with inflammation and pain but patient declined.
This spontaneous report as received from a nurse practitioner via a company representative refers to a female patient of unknown age. The patient's medical history was not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot #, dose, route and site of administration were not reported) for prophylaxis. Concomitant medications were unknown. On an unknown date, the patient developed shingles. She sought medical attention (unspecified). The outcome of event was unknown. The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA004417:
Information has been received from a nurse practitioner, via a company representative, concerning a 14 year old female patient, who was vaccinated on an unspecified date, with the second dose, 0.5 ml, of Gardasil (lot # not reported).  Subsequently, the patient experienced a "pit" (dent) on her arm where the injection was given.  At the time of this report, the patient had not recovered.  Additional information has been requested. Follow-up received 04/16/2008. Initial and follow-up information has been received from a nurse practitioner, concerning a 16 year old (previously reported as 14 year old) femal student with recurrent bronchitis, who on 10-JUL-2007 was vaccinated IM in the left deltoid with the first dose (lot #657006/D188U), and on 10-SEP-2007 was vaccinated in the left deltoid with the second dose, 0.5 ml. of GARDASIL vaccine (lot # 658490/0802U). There was no illness at the time of vaccination. Subsequently, the patient experienced a "pit" (dent), also described as 'dimpling" on her arm where the injection s were given. There was no pain at the injection site. At the time of this report, the outcome of the event was unknown. Additional information is not expected.
Within less than one minute, client became lightheaded followed by pallor, cool and clammy skin. Blood pressure 90/70 lying down. Transported by ambulance to hospital because continued to be lightheaded. At hospital, continued with same symptoms so kept overnight.  Nurse follow up on 07/23/04 states: "weakness and nausea."
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In DECEMBER 2016, a healthcare provider at a clinic administered the ZOSTAVAX (lot number, dosage and route of administration not provided) to the patient. In JANUARY 2017, the patient was treated by a healthcare provider at a clinic for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
This is a 2 y/o previously healthy male. He had a well-child examination performed on 6/18/07. where he received DTaP and Hib #4. One-two days after immunizations he developed (R) lower extremity (thigh) swelling and pain. 7/5/07-record received-seen on 6/20/07- C/O thrush on 6/18/07.Seen on 6/20/07 with C/O immunization reaction, swelling 2 days prior, leg red and swollen. PE: no over erythema or signs of infection, isolated rar raised lesions consistent with pityriasis. Right leg swelling
Within 15 min lower lip swelled slightly and began to itch. Felt some weakness in left leg. Within 4 hrs. from injection face turned bright red which has happened to me with past anaphylaxis events. I also experienced some racing of my heart. I did have what are considered normal reactions. Fever. Extreme fatigue. Chills. On Sunday the 5th I started having sensations of shaking on the inside. Like all my nerves were out of sorts. I had some balance issues. Stomach pain. Nausea. The shaking nerve feeling has continued on and off with last experience on 12/10/21.